Form 8-K - Current report:
SEC Accession No. 0001999371-25-005717
Filing Date
2025-05-08
Accepted
2025-05-08 17:16:06
Documents
13
Period of Report
2025-05-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_050825.htm   iXBRL 8-K 75796
  Complete submission text file 0001999371-25-005717.txt   251628

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20250508.xsd EX-101.SCH 3023
3 XBRL LABEL FILE tnxp-20250508_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE tnxp-20250508_pre.xml EX-101.PRE 24170
15 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_050825_htm.xml XML 3547
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 25927408
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)